The meeting will bring together leading experts in the field of oncology to explore the future of biomarker research and its clinical applications. This year’s focus includes molecular diagnostics, disruptive technologies, and artificial intelligence, shaping a ‘New Era of Biomarkers in Oncology’ to advance diagnosis, therapy monitoring, and patient care throughout the course of disease.
More than 300 participants are expected, including renowned scientists, experienced and early career researchers, medical clinicians, laboratory physicians, data scientists and technology specialists from across oncology. Together, they will share experiences on groundbreaking research, new biomarker technologies, and advancements in cancer diagnostics and treatment.
The conference is organized in cooperation with the annual Oncological Symposium of the Trillium Academy. For more detailed information and registration, please, visit the ISOBM conference website